Definitive Contract 75F40122C00100
Award Date
8/19/22
Potential Completion Date
3/31/28
Potential Value
$1.3M
Federal Agency
Food and Drug Administration
Ultimate Awardee
State Of Maryland Executive Office
NAICS Category
923120 - Administration of Public Health Programs
PSC Category
H265 - Equipment And Materials Testing- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the U.S. Food and Drug Administration (FDA) to The Environment Maryland Department Of Office Of Fiscal Services Division, doing business as State Of Maryland, for $705,383.99. The contract is for Mammography Quality Standards Act (MQSA) inspections and does not have a set-aside designation. As the state environmental protection agency, The Environment Maryland Department is responsible for various environmental programs, monitoring activities, and...
The U.S. Food and Drug Administration (FDA) awarded a firm fixed price definitive contract worth $561,988.56 to the Maryland Department of Health Prevention & Health Promotion Administration - Ideha Division, operating under the State of Maryland, to conduct human food inspections in Baltimore, Maryland. The contract has an ultimate completion date of September 29, 2026. This contract supports the FDA's food safety efforts by leveraging the state-level expertise and resources of the Maryland...
This is a $2,685,565.01 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH) for Massachusetts MQSA (Mammography Quality Standards Act) new contract services. The contract has no set-aside designation and an ultimate completion date of January 21, 2028. MDPH, a U.S. state government agency, is the prime contractor and will provide specialized public health services to the FDA, including food and tobacco...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
This $20,877.28 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) to the State of Maryland Division of the Maryland Small Business Development Financing Authority. The award is for providing environmental licenses and does not have a set-aside designation. The State of Maryland is a U.S. state government entity that serves as a prime contractor to federal agencies, delivering a wide range of products and services. The state has an indefinite delivery contract...
This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to the Connecticut Department of Energy & Environmental Protection (DEEP). The contract, valued at $1,817,587.32, is for services related to the FDA's Mammography Quality Standards Act (MQSA) program, which regulates mammography facilities. The contract has a period of performance ending on September 29, 2027 and is a firm fixed-price contract. The contract was not set aside for any specific...
The U.S. Food and Drug Administration (FDA) awarded a firm fixed price definitive contract to the Maryland Department of Health's Prevention & Health Promotion Administration - Ideha Division to provide critical food inspection services in Baltimore, Maryland from August 2016 through September 2018. The contract had a ceiling value of $355,594.69. The contract work supports the FDA's role in ensuring food safety and public health through state-level collaboration and inspections. The...
This federal contract, awarded by the Food and Drug Administration (FDA) to the Executive Office of the Governor of Delaware, Division of Public Health, is for the DELAWARE MQSA INSPECTION CONTRACT. The contract is a Definitive Contract with a Firm Fixed Price pricing type, with a ceiling value of $235,491.31 and an ultimate completion date of August 31, 2027. The contract is not set aside for any specific designation. The contract requires the Division of Public Health to conduct inspections of...
This is a firm fixed-price federal contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH), a state government agency, for food inspections. The contract has a ceiling value of $140,191.49 and an ultimate completion date of September 29, 2005. This contract is not set aside and is part of the MDPH's broader work as a prime contractor and grant recipient providing public health services to federal agencies. MDPH has also been awarded...